Anjarium Biosciences
Edit

Anjarium Biosciences

http://www.anjarium.com/
Tags:BioTechDeliveryDrugHealthTechPersonalPlatformScienceTechnology
Anjarium Biosciences AG is a genetic medicines company focused on creating and delivering a new generation of targeted gene therapies to patients. Anjarium’s versatile platform builds on novel therapeutic payloads and delivery technologies, with the aim to unlock the full potential of gene therapy.
Location: Switzerland, Zurich, Schlieren
Member count: 11-50
Total raised: $61M
Founded date: 2017

Investors 3

DateNameWebsite
15.01.2022Omega Fund...omegafunds...
06.08.2021Abingworth...abingworth...
16.06.2022GIMVgimv.com

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
16.09.2021Series A$61M-finsmes.co...

Mentions in press and media 16

DateTitleDescriptionCategoryAuthorSource
13.01.2023Seasoned e... Giancarlo Rizzoli has taken ...Support-startuptic...
30.12.2022Experience... Fintech startup Tresio is a ...Support-startuptic...
16.12.2022Newly hire... NXI Therapeutics, a spin-off...Support-startuptic...
20.07.2022Executive ... Airconsole – from CTO to CEO...Support-startuptic...
29.06.2022New C-Suit... With his experience and focu...Support-startuptic...
28.01.2022Schlieren ... Gene therapies are becoming ...Support-startuptic...
20.09.2021Digital he...Biden administration seeks to ...-Kristin Ka...vator.tv/n...
18.09.2021Daily fund...Francis Medical raised $55M; C...-Kristin Ka...vator.tv/n...
17.09.2021Daily fund...Francis Medical raised $55M; C...-Kristin Ka...vator.tv/n...
16.09.2021Anjarium B...---abingworth...
Show more